Skip to content
value.today

Baumer vs Harvard Bioscience, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Harvard Bioscience, Inc. is the larger company by market value: $38 M against $20 M for Baumer, 1.9 times as much (market caps of Jul 30, 2023 for Baumer and Oct 26, 2026 for Harvard Bioscience, Inc.). Baumer's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0581151732312020202120222023202420252026Baumer 77Harvard Bioscience, Inc. 32

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025Harvard Bioscience, Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureBaumer
BALM4.SA
Harvard Bioscience, Inc.
HBIO · #22,291 in the world
Profile
Country🇧🇷 Brazil🇺🇸 USA
SectorHealthcareHealthcare
IndustryMedical InstrumentsMedical Instruments
Founded—1901
Size
Market cap$20 M*$38 M
Revenue—$87 M
Net income—$-57 M
Valuation
Price to sales—0.4×
Price to book—2.7×
Free cash flow yield—14.5%
Profitability
Gross margin—57.7%
Operating margin—-56.1%
Net margin—-65.5%
Return on equity—-147.1%
Growth
Revenue growth—-8.1%
Revenue growth, 3 years a year—-8.6%
Financial strength
Debt to equity—2.6×
Interest cover—-37.4×
Cash
Free cash flow margin—6.3%
Strength scores
Piotroski F-score—5 of 9
Altman Z-score zone—distress
Data as ofMarket cap Jul 2023Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Baumer or Harvard Bioscience, Inc.?

Harvard Bioscience, Inc. is the larger company by market value: $38 M against $20 M for Baumer, 1.9 times as much (market caps of Jul 30, 2023 for Baumer and Oct 26, 2026 for Harvard Bioscience, Inc.). Baumer's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.

Sources#

Every figure on this page comes from these, with the date shown next to it.